{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T15:37:37Z","timestamp":1792337857561,"version":"4.4.0"},"reference-count":0,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2014,2,1]],"date-time":"2014-02-01T00:00:00Z","timestamp":1391212800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["PPA"],"DOI":"10.2147\/ppa.s55382","type":"journal-article","created":{"date-parts":[[2014,2,14]],"date-time":"2014-02-14T03:16:50Z","timestamp":1392347810000},"page":"211","source":"Crossref","is-referenced-by-count":55,"title":["Proportion and risk indicators of nonadherence to antihypertensive therapy: a meta-analysis"],"prefix":"10.2147","author":[{"given":"Mark","family":"Lemstra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wasem","family":"Alsabbagh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2014,2]]},"container-title":["Patient Preference and Adherence"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=18993","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2016,10,30]],"date-time":"2016-10-30T22:14:15Z","timestamp":1477865655000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.dovepress.com\/proportion-and-risk-indicators-of-nonadherence-to-antihypertensive-the-peer-reviewed-article-PPA"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2]]},"references-count":0,"URL":"https:\/\/doi.org\/10.2147\/ppa.s55382","relation":{},"ISSN":["1177-889X"],"issn-type":[{"value":"1177-889X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,2]]}}}